Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 6/2013

01-12-2013 | Psychosocial Aspects (KK Hood, Section Editor)

The Challenges and Future Considerations Regarding Pregnancy-Related Outcomes in Women with Pre-Existing Diabetes

Authors: Harsimran Singh, Helen R. Murphy, Christel Hendrieckx, Lee Ritterband, Jane Speight

Published in: Current Diabetes Reports | Issue 6/2013

Login to get access

Abstract

Ineffective management of blood glucose levels during preconception and pregnancy has been associated with severe maternal and fetal complications in women with pre-existing diabetes. Studies have demonstrated that preconception counseling and pre-pregnancy care can dramatically reduce these risks. However, pregnancy-related outcomes in women with diabetes continue to be less than ideal. This review highlights and discusses a variety of patient, provider, and organizational factors that can contribute to these suboptimal outcomes. Based on the findings of studies reviewed and authors’ clinical and research experiences, recommendations have been proposed focusing on various aspects of care provided, including improved accessibility to effective preconception and pregnancy-related care and better organized clinic consultations that are sensitive to women’s diabetes and pregnancy needs.
Literature
1.
Negrato CA, Mattar R, Gomes MB. Adverse pregnancy outcomes in women with diabetes. Diabetol Metab Syndr. 2012;4:41.PubMedCrossRef
2.
Kitzmiller JL, Block JM, Brown FM, et al. Managing pre-existing diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care. 2008;31:1060–79.PubMedCrossRef
3.
• de Valk HW, Visser GH. Insulin during pregnancy, labour, and delivery. Best Pract Res Clin Obstet Gynaecol. 2011;25:65–76. This article offers a good description of the changes in insulin requirements during pregnancy and details of insulin therapy that helps women with pre-existing diabetes regulate their blood glucose levels during pregnancy. PubMedCrossRef
4.
5.
6.
Jovanovic L, Knopp RH, Brown Z, et al. Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care. 2001;24:1130–6.PubMedCrossRef
7.
Trujillo AL. Insulin analogs and pregnancy. Diabetes Spectrum. 2007;20:94–101.CrossRef
8.
Murphy HR, Elleri D, Allen JM. Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia. 2012;55:282–93.PubMedCrossRef
9.
American Diabetes Association. Preconception care of women with diabetes. Diabetes Care. 2004;(Suppl 1):S76–8.
10.
11.
Penney GC, Mair G, Pearson DW. Outcomes of pregnancies in women with type 1 diabetes in Scotland: a nation population-based study. BJOG. 2003;110:315–8.PubMedCrossRef
12.
Boulot P, Chabbert-Buffet N, d’Ercole C, et al. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care. 2003;26:2990–3.PubMedCrossRef
13.
Ekbom P, Damm P, Nøgaard K, et al. Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in type I diabetes. Diabetologia. 2000;43:927–31.PubMedCrossRef
14.
Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in The Netherlands. BMJ. 2004;17;328:915.
15.
Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004;27:2819–23.PubMedCrossRef
16.
Lapolla A, Dalfrà MG, Spezia R, et al. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetol. 2008;45:61–6.PubMedCrossRef
17.
Macintosh MC, Fleming KM, Bailey JA, et al. A perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;22;333:177.
18.
Vargas R, Repke JT, Ural SH. Type 1 diabetes mellitus and pregnancy. Rev Obstet Gynecol. 2010;3:92–100.PubMed
19.
• Ringholm L, Pederson-Bjergaard U, Thorsteinsson B, et al. Hypoglycemia during pregnancy in women with Type 1 diabetes. Diabet Med. 2012;29:558–66. This article offers a very good review of the incidence, risk factors, and clinical management of hypoglycemia during pregnancy in pregnant women with type 1 diabetes. PubMedCrossRef
20.
Rosenn BM, Miodovnik M, Khoury JC, et al. Counterregulatory hormonal responses to hypoglycemia during pregnancy. Obstet Gynecol. 1996;87:568–74.PubMedCrossRef
21.
Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care. 1995;18:631–7.PubMedCrossRef
22.
Brindley BG, Jovanovic L. Pregnancy in adolescents with type 1 diabetes. Growth, Genetics, & Hormones. 2004;20:49–55.
23.
Feig D, Palda V. Type 2 diabetes in pregnancy: a growing concern. Lancet. 2002;11(359):1690–2.CrossRef
24.
Bell R, Baily K, Cresswell T, et al. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG. 2008;115:445–52.PubMedCrossRef
25.
Lusignan S, Sismanidis C, Carey IM, et al. Trends in the prevalence and management of diagnosed type 2 diabetes 1994–2001 in England and Wales. BMC Fam Pract. 2005;22;6:13.
26.
Temple RC, Murphey H. Type 2 diabetes in pregnancy - an increasing problem. Best Pract Res Clin Endocrinol Metab. 2010;24:591–603.PubMedCrossRef
27.
Murphy HR, Rayman G, Duffield K, et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care. 2007;30:2785–91.PubMedCrossRef
28.
•• Balsells M, García-Patterson A, Gich I, et al. Maternal and fetal outcome in women with type 2 vs type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2009;94:4284–91. This article presents a useful review of the comparisons between maternal and fetal outcomes in women with type 1 and type 2 diabetes. PubMedCrossRef
29.
Murphy HR, Steel SA, Roland JM, et al. Obstetric and perinatal outcomes in pregnancies complicated by type 1 and type 2 diabetes: influences of glycaemic control, obesity and social disadvantage. Diabet Med. 2011;28:1060–7.PubMedCrossRef
30.
Lee-Parritz A. New technologies for the management of pregestational diabetes mellitus. Obstet Gynecol Surv. 2012;67:167–75.PubMedCrossRef
31.
Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med. 1990;7:360.
32.
Colstrup M, Mathiesen ER, Damm P, et al. Pregnancy in women with type 1 diabetes: have the goals of St. Vincent's declaration been met concerning fetal and neonatal complications? J Matern Fetal Neonatal Med. 2013; [Epub ahead of print].
33.
Kinsley B. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus. Clin Ther. 2007;29(Suppl D):S153–60.PubMedCrossRef
34.
Kitzmiller JL, Buchanan TA, Kjos S, et al. Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care. 1996;19:514–41.PubMed
35.
Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM. 2001;94:435–44.PubMedCrossRef
36.
American Diabetes Association. Standards of Medical Care in Diabetes–2013. Diabetes Care. 2013;36 Suppl 1:S11–66.CrossRef
37.
Wahabi HA, Alzeidan RA, Bawazeer GA, et al. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2010;14;10:63.
38.
Tripathi A, Rankin J, Aarvold J, et al. Preconception counseling in women with diabetes: a population-based study in the north of England. Diabetes Care. 2010;33:586–8.PubMedCrossRef
39.
Pearson DW, Kernaghan D, Lee R, et al. The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes mellitus. BJOG. 2007;114:104–7.PubMedCrossRef
40.
Bell R, Glinianaia SV, Tennant PW, et al. Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia. 2012. [Epub ahead of print].
41.
Chuang CH, Chase GA, Bensyl DM, et al. Contraceptive use by diabetic and obese women. Women’s Health Issues. 2005;15:167–73.PubMedCrossRef
42.
Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United Sates, 1994 and 2001. Perspect Sex Reprod Health. 2006;38:90–6.PubMedCrossRef
43.
Schwarz EB, Postlethwaite D, Hung YY, et al. Provision of contraceptive services to women with diabetes mellitus. J Gen Intern Med. 2012;27:196–201.PubMedCrossRef
44.
Kim C, Ferrara A, McEwen LN, et al. Preconception care in managed care: the translating research into action for diabetes study. Am J Obstet Gynecol. 2005;192:227–32.PubMedCrossRef
45.
Makda SI, Davies MJ, Wilmot E, et al. Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception. Diabet Med. 2013;30:457–63.PubMedCrossRef
46.
Evers IM, ter Braak EW, de Valk H, et al. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care. 2002;25:554–9.PubMedCrossRef
47.
Rosenn BM, Miodovnik M, Holcberg G, et al. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol. 1995;85:417–22.PubMedCrossRef
48.
Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, et al. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care. 2008;31:9–14.PubMedCrossRef
49.
Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, et al. Hypoglycemia in pregnant women with type 1 diabetes: clinical features and management. Diabetic Hypoglycemia. 2011;3:3–7.
50.
Delamater AM, Jacobson AM, Anderson B, et al. Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group. Diabetes Care. 2001;24:1286–92.PubMedCrossRef
51.
Stenhouse E, Letherby G. Mother/daughter relationships during pregnancy and the transition to motherhood of women with pre-existing diabetes: raising some issues. Midwifery. 2011;27:120–4.PubMedCrossRef
52.
Rasmussen B, Dunning T, Hendrieckx C, et al. Transition to motherhood in type 1 diabetes: design of the pregnancy and postnatal well-being in transition questionnaires. BMC Pregnancy Childbirth. 2013;13:54.PubMedCrossRef
53.
54.
Langer N, Langer O. Pre-existing diabetics: relationship between glycemic control and emotional status in pregnancy. J Matern Fetal Med. 1998;7:257–63.PubMedCrossRef
55.
56.
Berg M, Lundgren I, Lindmark G. Childbirth experience in women at high risk: is it improved by use of a birth plan? J Perinat Educ. 2003;12:1–15.PubMed
57.
Gupton A, Heaman M, Cheung LW. Complicated and uncomplicated pregnancies: women's perception of risk. J Obstet Gynecol Neonatal Nurs. 2001;30:192–201.PubMedCrossRef
58.
Hatmaker DD, Kemp VH. Perception of threat and subjective well-being in low-risk and high-risk pregnant women. J Perinat Neonatal Nurs. 1998;12:1–10.PubMedCrossRef
59.
Berg M, Honkasalo ML. Pregnancy and diabetes: a hermeneutic phenomenological study of women's experiences. J Psychosom Obstet Gynaecol. 2000;21:39–48.PubMedCrossRef
60.
McCorry NK, Hughes C, Spence D, et al. Pregnancy planning and diabetes: a qualities exploration of women’s attitudes toward preconception care. J Midwifery Womens Health. 2012;57:396–402.PubMedCrossRef
61.
Lavender T, Platt MJ, Tsekiri E, et al. Women’s perceptions of being pregnant and having pregestational diabetes. Midwifery. 2010;26:589–95.PubMedCrossRef
62.
King R, Wellard S. Juggling type 1 diabetes and pregnancy in rural Australia. Midwifery. 2009;25:126–33.PubMedCrossRef
63.
Holing EV, Beyer CS, Brown ZA, et al. Why don't women with diabetes plan their pregnancies? Diabetes Care. 1998;21:889–95.PubMedCrossRef
64.
Berg M, Sparud-Lundin C. Experiences of professional support during pregnancy and childbirth—a qualitative study of women with type 1 diabetes. BMC Pregnancy Childbirth. 2009;3;9:27.
65.
Murphy HR, Temple RC, Ball VE, et al. Personal experiences of women with diabetes who do not attend pre-pregnancy care. Diabet Med. 2010;27:92–100.PubMedCrossRef
66.
Charron-Prochownik D, Ferons-Hannan M, Sereika S, et al. Randomized efficacy trial of early preconception counseling for diabetic teens (READY-girls). Diabetes Care. 2008;31:1327–30.PubMedCrossRef
67.
Murphy HR, Roland JM, Skinner TC, et al. Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care. 2010;33:2514–20.PubMedCrossRef
68.
ACOG technical bulletin. Preconceptional care. Number 205—May 1995. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 1995;50:201–7.CrossRef
69.
Zhu H, Graham D, Teh RW, et al. Utilisation of preconception care in women with pregestational diabetes in western Australia. Aust N Z J Obstet Gynaecol. 2012;52:593–6.PubMedCrossRef
70.
Kitzmiller JL, Wallerstein R, Correa A, et al. Preconception care for women with diabetes and prevention of major congenital malformations. Birth Defects Res A Clin Mol Teratol. 2010;88:791–803.PubMedCrossRef
71.
Owens MD, Kieffer EC, Chowdhury FM. Preconception care and women with or at risk for diabetes: implications for community intervention. Matern Child Health J. 2006;10(5 Suppl):S137–41.PubMedCrossRef
72.
Janz NK, Herman WH, Becker MP, et al. Diabetes and pregnancy. Factors associated with seeking preconception care. Diabetes Care. 1995;18:157–65.PubMedCrossRef
73.
Casele HL, Laifer SA. Factors influencing preconception control of glycemia in diabetic women. Arch Intern Med. 1998;22(158):1321–4.CrossRef
74.
Korenbrot CC, Steinberg A, Bender C, et al. Preconception care: a systematic review. Matern Child Health J. 2002;6:75–88.PubMedCrossRef
75.
Bernasko J. Contemporary management of type 1 diabetes mellitus in pregnancy. Obstet Gynecol Surv. 2004;59:628–36.PubMedCrossRef
76.
Kendrick JM. Preconception care of women with diabetes. J Perinat Neonatal Nurs. 2004;18:14–25. quiz 26–7.PubMedCrossRef
77.
American Diabetes Association. Preconception care of women with diabetes. Diabetes Care. 2003;26:91S–3S.CrossRef
78.
79.
Downs JS, Arslanian S, de Bruin WB, et al. Implications of type 2 diabetes on adolescent reproductive health risk: an expert model. Diabetes Educ. 2010;36:911–9.PubMedCrossRef
80.
Romano AM. A changing landscape: implications of pregnant women's internet use for childbirth educators. J Perinat Educ. 2007;16:18–24.PubMedCrossRef
81.
Sparud-Lundin C, Ranerup A, Berg M. Internet use, needs and expectations of web-based information and communication in childbearing women with type 1 diabetes. BMC Med Inform Decis Mak. 2011;7;11:49.
82.
Ritterband L, Gonder-Frederick L, Cox D, et al. Internet interventions: In review, in use, and into the future. Professional Psychology: Research and Practice. 2003;34:527–34.CrossRef
Metadata
Title
The Challenges and Future Considerations Regarding Pregnancy-Related Outcomes in Women with Pre-Existing Diabetes
Authors
Harsimran Singh
Helen R. Murphy
Christel Hendrieckx
Lee Ritterband
Jane Speight
Publication date
01-12-2013
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 6/2013
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-013-0417-5

Other articles of this Issue 6/2013

Current Diabetes Reports 6/2013 Go to the issue

Genetics (TM Frayling, Section Editor)

What the Genetics of Lipodystrophy Can Teach Us About Insulin Resistance and Diabetes

Diabetes Epidemiology (SH Golden, Section Editor)

Epidemiology of Diabetes and Diabetes Complications in the Elderly: An Emerging Public Health Burden

Psychosocial Aspects (KK Hood, Section Editor)

Psychological Care in a National Health Service: Challenges for People with Diabetes

Psychosocial Aspects (KK Hood, Section Editor)

Impact of Behavioral Interventions in the Management of Adults with Type 2 Diabetes Mellitus

Diabetes Epidemiology (SH Golden, Section Editor)

Environmental Chemicals and Type 2 Diabetes: An Updated Systematic Review of the Epidemiologic Evidence

Psychosocial Aspects (KK Hood, Section Editor)

Technology to Optimize Pediatric Diabetes Management and Outcomes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits